Clinical Trials Directory

Trials / Conditions / Seizures

Seizures

212 registered clinical trials studyying Seizures32 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingCholinergic Enhancement of Theta
NCT07228338
University of Texas Southwestern Medical CenterEARLY_Phase 1
Not Yet RecruitingStudy of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age Wit
NCT06534502
Azurity PharmaceuticalsPhase 4
CompletedPilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Ho
NCT07257705
University of Milano BicoccaN/A
RecruitingProphylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brai
NCT07130786
Ayal A. Aizer, MDPhase 2
RecruitingLEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
NCT07234695
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauPhase 3
Not Yet RecruitingClinical Profile And Outcomes Of Neonatal Convulsions In The Neonatal Intensive Care Unit At Assiut University
NCT07274410
Assiut University
Active Not RecruitingBHV-7000 Responsive Neurostimulation System (RNS) Study
NCT07125261
Yale UniversityPhase 1
RecruitingEarly Post-Traumatic Seizures Prevention Trial (E-PTS Trial)
NCT07072624
All India Institute of Medical Sciences, JodhpurPhase 4
CompletedComparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With Ecl
NCT06997575
Nishtar Medical UniversityPhase 4
Active Not RecruitingA Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Ar
NCT06714448
Sanofi
RecruitingEar-Seizure Detection (EarSD) Study
NCT06598189
Felicia ChuN/A
RecruitingSeizure Identification on the Intensive Care Unit (ICU)
NCT07136298
Nottingham University Hospitals NHS Trust
Not Yet RecruitingLevetiracetam Prophylaxis in Brain Tumor Resection Pilot
NCT05897658
Hamilton Health Sciences CorporationPhase 3
WithdrawnEfficacy of Intersectional Short Pulse Stimulation for Terminating Seizures
NCT04998123
NYU Langone HealthN/A
Not Yet RecruitingDecreasing Postoperative Blood Loss and Seizures by Timing of Intravenous Tranexamic Acid 2 Pilot Trial
NCT06622564
Hamilton Health Sciences CorporationPhase 3
CompletedInvestigation of the Effects of Pilates Training in Patients With Drug-Resistant Epilepsy
NCT06754124
Recep Tayyip Erdogan University Training and Research HospitalN/A
UnknownBoosting The Intervention Effect of Negative Memory Through tACS Stimulation
NCT06375395
Xuanwu Hospital, BeijingN/A
RecruitingShort Versus Long-term Levetiracetam in Brain Tumors
NCT06442748
Tata Memorial CentrePhase 3
RecruitingPeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
NCT06401707
University of California, San FranciscoPhase 2
SuspendedGlioblastoma Remote Monitoring and Care - Research Protocol
NCT06129760
Case Comprehensive Cancer CenterN/A
RecruitingConnectivity and Neural Signatures of Consciousness in Unresponsive States
NCT06426615
Universitaire Ziekenhuizen KU LeuvenN/A
CompletedDetecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
NCT06093490
Eysz, Inc.
RecruitingOxygen Toxicity: Mechanisms in Humans
NCT05761756
Duke UniversityN/A
TerminatedTransnasal Induction of Normothermia for Neurogenic Fever
NCT06038513
CoolTech LLCN/A
RecruitingImpact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring Sys
NCT06027749
Epitel, Inc.N/A
UnknownElectrocardiographic Changes Among Epileptic and Non Epileptic Seizures in Children at Sohag University Hospit
NCT06045676
Sohag University
UnknownChecklists Resuscitation Emergency Department
NCT05649891
Region SkaneN/A
RecruitingbuRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
NCT05851391
University of California, San FranciscoPhase 2
CompletedComparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Dee
NCT06067750
Nottingham University Hospitals NHS Trust
RecruitingAcute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
NCT05784805
Yale UniversityN/A
RecruitingPredisposing Factors for Post-stroke Epilepsy
NCT05864547
Norwegian University of Science and Technology
Active Not RecruitingLong-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
NCT05772429
Jazz Pharmaceuticals
WithdrawnEpiCare@Home Validation Study for Focal Onset Seizures
NCT05738226
BytefliesN/A
WithdrawnThalamic Stimulation for Epilepsy Study
NCT04102254
Duke UniversityN/A
Active Not RecruitingRNS System LGS Feasibility Study
NCT05339126
NeuroPacePhase 2
RecruitingPediatric Dose Optimization for Seizures in Emergency Medical Services
NCT05121324
Stanford UniversityPhase 3
RecruitingInvestigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Chi
NCT05219617
SK Life Science, Inc.Phase 3
CompletedPivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
NCT04770337
Neuroelectrics CorporationN/A
RecruitingDe-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
NCT05140265
University of New Mexico
CompletedPropofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
NCT05103735
Azienda Sanitaria-Universitaria Integrata di Udine
RecruitingRegister for Patients With Thyroid Hormone Resistance.
NCT06566066
Charite University, Berlin, Germany
UnknownComparing the Efficacy of Intranasal Midazolam Versus Intravenous Diazepam for Control of Seizures in Children
NCT04885075
Shaheed Zulfiqar Ali Bhutto Medical UniversityPhase 4
UnknownObservational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Syncopation a
NCT04879147
Ruhr University of Bochum
CompletedSeizures and Traumatic Brain Injury Rehabilitation
NCT05823168
Istituti Clinici Scientifici Maugeri SpA
TerminatedAn Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures
NCT04686786
AbbViePhase 2
UnknownMultimodal Neuromonitoring
NCT04737369
Medical University of Vienna
CompletedEffect of Perampanel on Peritumoral Hyperexcitability in HGG
NCT04497142
Dana-Farber Cancer InstitutePhase 1 / Phase 2
CompletedThe Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection
NCT04595786
Beijing Tiantan HospitalN/A
CompletedStudy on Optic Nerve Sheath Diameter Measurements in Prolonged Pediatric Seizures
NCT06451289
Balikesir University
CompletedDetecting Absence Seizures Using Eye Tracking
NCT04439656
Rachel Kuperman
UnknownStudy to Validate Novel Seizure-Detection Algorithm
NCT04291716
Overwatch Digital HealthN/A
TerminatedThe Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy
NCT04193891
University of Wisconsin, Madison
CompletedA Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures
NCT04244175
AbbViePhase 2
CompletedA Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or S
NCT04202159
Eisai GmbH
CompletedThe Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumon
NCT04325685
Northern State Medical UniversityN/A
UnknownDiagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE)
NCT04211233
University Clinic FrankfurtN/A
CompletedAdvancing Understanding of Transportation Options
NCT04141891
University of Colorado, DenverN/A
UnknownCorrelation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER
NCT04118829
Carilion ClinicPhase 4
CompletedIntramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children
NCT06271096
Arooj KhanEARLY_Phase 1
UnknownAssessment of the Emfit Mattress Sensor for Detection and Alarm of Night-time Generalized Tonic-clonic Seizure
NCT02661919
Emfit, Corp.N/A
TerminatedDEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Su
NCT03954314
Population Health Research InstitutePhase 3
RecruitingQuantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Relate
NCT04076449
yuanli Zhao
RecruitingPharmacological Modulation of Brain Oscillations in Memory Processing
NCT05594017
University of Texas Southwestern Medical CenterEARLY_Phase 1
CompletedNeurology Inpatient Clinical Education Trial
NCT03826056
Dartmouth-Hitchcock Medical CenterN/A
CompletedAggressive Antipyretics for Fever Reduction in CNS Malaria
NCT03399318
University of RochesterPhase 2
CompletedEvaluating the Role of Inflammation in Neonatal Epileptogenesis
NCT04259125
University of California, San Francisco
UnknownOutcomes Mandate National Integration With Cannabis as Medicine
NCT03944447
OMNI Medical Services, LLCPhase 2
UnknownObservance of Anticonvulsant Treatments and Quality of Life of Epileptic Children
NCT03753035
Central Hospital, Nancy, France
CompletedA Study of Intravenous Perampanel in Japanese Participants With Epilepsy
NCT03754582
Eisai Co., Ltd.Phase 2
CompletedDatabase Of Clinical Data For Individuals With Variants In The IRF2BPL Gene
NCT03892798
Children's Hospital Medical Center, Cincinnati
CompletedThe Study of Pharmacokinetics of Levetiracetam in Patients Undergoing Intermittent Hemodialysis
NCT04511676
Phramongkutklao College of Medicine and Hospital
CompletedEarly Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
NCT03722212
METAFORA biosystemsN/A
TerminatedBetaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet
NCT03790436
University of Southern CaliforniaN/A
WithdrawnBiomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)
NCT02298647
CENTOGENE GmbH Rostock
CompletedA Safety Study For Prevenar 13 Among Chinese Children
NCT03656939
Pfizer
RecruitingLongitudinal Study of Neurogenetic Disorders
NCT03492060
Columbia University
CompletedDoes Use of Rapid Response EEG Impact Clinical Decision Making
NCT03534258
Ceribell Inc.
CompletedSeizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis
NCT04022486
Hospices Civils de Lyon
RecruitingInvestigating Epilepsy: Screening and Evaluation
NCT03478852
National Institute of Neurological Disorders and Stroke (NINDS)
CompletedRegistry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
NCT03529045
LivaNova
CompletedThe Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia.
NCT04323150
Northern State Medical UniversityN/A
CompletedTransnasal Induction of Normothermia in Febrile Stroke Patients
NCT03360656
CoolTech LLCN/A
UnknownAcute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy
NCT05422664
Liu Yonghong
CompletedDevelopment of an Epileptic Seizure Detection Algorithm by Continuous Analysis of the Electrocardiogram
NCT03369522
University Hospital, Lille
CompletedReview of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years
NCT03561168
Baylor College of Medicine
RecruitingModulating Movement Intention Via Cortical Stimulation
NCT03233399
NYU Langone HealthN/A
UnknownDoes Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?
NCT03054285
Loyola UniversityPhase 4
RecruitingElectrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
NCT03419260
Children's Hospital of Philadelphia
CompletedHypomagnesemia Associated With Proton-Pump Inhibitor Use
NCT04426994
Changi General Hospital
UnknownA Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
NCT03934268
Children's Hospital of Fudan University
CompletedHypovitaminosis D in Neurocritical Patients
NCT02881957
University of UtahPhase 2 / Phase 3
UnknownDoxycycline for the Treatment of Nodding Syndrome
NCT02850913
Makerere UniversityPhase 2
CompletedEfficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures
NCT02897856
Hamad Medical CorporationPhase 4
CompletedAn Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWP
NCT02544750
Jazz PharmaceuticalsPhase 3
RecruitingEtiology and Treatment of Neonatal Seizure
NCT03822741
Children's Hospital of Fudan University
Active Not RecruitingNeural Circulatory Control and SUDEP Risk.
NCT02813980
Mayo Clinic
RecruitingGenetic Markers of Cardiovascular Disease in Epilepsy
NCT02824822
Mayo Clinic
UnknownDuration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome
NCT03181945
Post Graduate Institute of Medical Education and Research, ChandigarhN/A
CompletedA Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWP
NCT02544763
Jazz PharmaceuticalsPhase 3
CompletedCognitive Recovery After Electroconvulsive Therapy and General Anesthesia
NCT02761330
Washington University School of MedicineN/A
CompletedCannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
NCT02318602
INSYS Therapeutics IncPhase 3
RecruitingEpidemiology Study on Neonatal Seizure
NCT02552511
Children's Hospital of Fudan University
CompletedPrompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest
NCT02458820
Children's Hospital of PhiladelphiaN/A
CompletedVagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation
NCT02385526
Cyberonics, Inc.
CompletedCannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
NCT02324673
INSYS Therapeutics IncPhase 1 / Phase 2
CompletedUniversity of Alabama at Birmingham (UAB) Adult CBD Program
NCT02700412
University of Alabama at BirminghamPhase 1
CompletedUniversity of Alabama at Birmingham (UAB) Pediatric CBD Program
NCT02695537
University of Alabama at BirminghamPhase 1
CompletedA Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection
NCT02431780
University College CorkN/A
TerminatedNovel Epidermal Recording and Detection of Seizures
NCT02451618
Sharp HealthCare
WithdrawnEarly Versus Late Intubation Trial in Physician Manned Emergency Medical Services
NCT01730001
Norwegian Air Ambulance FoundationN/A
TerminatedEEG in Resuscitated In-hospital Patients
NCT02349087
Kuopio University Hospital
Active Not RecruitingEpilepsy Watch After Vascular Events: Frequency, Outcomes, and Risk Markers
NCT06922734
University Medical Centre Maribor
TerminatedComparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management
NCT02409433
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sPhase 4
CompletedPhase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
NCT02019667
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2
CompletedPharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects
NCT02332174
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 1
TerminatedSeizure Prophylaxis in Aneurysm Repair
NCT01974700
Indiana UniversityPhase 4
CompletedRevisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surger
NCT01897974
Vidya Raman
CompletedExercise Education for Adults With Seizure Disorders
NCT01856335
National Institute of Neurological Disorders and Stroke (NINDS)EARLY_Phase 1
WithdrawnSeizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study
NCT01935908
Vanderbilt University Medical CenterPhase 4
WithdrawnTreatment Resistant Epilepsy and N-Acetyl Cysteine
NCT02054949
Nationwide Children's HospitalN/A
UnknownmicroEEG for Neonatal Apnea, Bradycardia and Desaturation
NCT02436616
Bio-Signal Group Corp.
CompletedBiomarkers In Seizure To Predict Recurrence and Severe Outcomes
NCT01774500
Bistro Study Group
TerminatedDose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizu
NCT01721317
GlaxoSmithKlinePhase 4
CompletedSeizure Activity in Alzheimer's Disease
NCT01554683
Beth Israel Deaconess Medical CenterN/A
TerminatedBuspirone Therapy for Localized Epilepsy
NCT01496612
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2
CompletedPharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
NCT01431326
Daniel Benjamin
TerminatedStudy on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at
NCT01478035
M. Carmen Cabellos MinguezPhase 4
CompletedClosed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy
NCT01415362
Spaulding Rehabilitation HospitalN/A
UnknownNeuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy
NCT01320670
Nova Scotia Health Authority
CompletedDrug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-recep
NCT01338363
AstraZeneca
TerminatedPrevention of Photoparoxysmal Abnormalities by Mozart K448
NCT01363154
Medical University of South CarolinaN/A
CompletedPediatric Seizure Movement Bed Alarm
NCT01855178
Le Bonheur Children's Hospital
CompletedBelgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizure
NCT01236001
UCB Pharma
CompletedDosing of Levetiracetam (Keppra) in Neonates
NCT01239212
Children's Hospital Medical Center, CincinnatiPhase 1 / Phase 2
UnknownStudy of Verapamil in Refractory Epilepsy
NCT01126307
University Health Network, TorontoN/A
CompletedPilot Study of Bumetanide for Newborn Seizures
NCT00830531
Soul, Janet , M.D.Phase 1
CompletedThe Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy
NCT01027715
Washington University School of MedicineN/A
CompletedCrossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
NCT01703468
Roxane LaboratoriesPhase 1
CompletedCrossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
NCT01702623
Roxane LaboratoriesPhase 1
CompletedEvaluation of StatNet Device for Electroencephalogram (EEG) Recordings
NCT03103425
Beth Israel Deaconess Medical Center
CompletedMagnetoencephalography in Absence Seizures
NCT00884351
National Institute of Neurological Disorders and Stroke (NINDS)
CompletedEfficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epileps
NCT00887861
NovartisPhase 2
CompletedDetermination of Absorption and Elimination of Lamotrigine-XR
NCT00789113
University of MinnesotaPhase 1 / Phase 2
CompletedPharmacokinetics of Levetiracetam (Keppra) in Neonates
NCT01261416
Children's Hospital Medical Center, Cincinnati
CompletedNasal Versus Venous Lorazepam for Control of Acute Seizures in Children
NCT00735527
All India Institute of Medical SciencesPhase 3
CompletedLong Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients
NCT00697918
SK Life Science, Inc.Phase 3
WithdrawnSeizure Therapy With Intravenous Levetiracetam and Lorazepam
NCT00465244
Massachusetts General HospitalPhase 2 / Phase 3
TerminatedCarisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability
NCT00563459
SK Life Science, Inc.Phase 3
TerminatedEffectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Parti
NCT00697762
SK Life Science, Inc.Phase 3
CompletedClobazam in Patients With Lennox-Gastaut Syndrome
NCT00518713
Lundbeck LLCPhase 3
CompletedBioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions
NCT00827320
Roxane LaboratoriesN/A
CompletedBioequivalency Study of Levetiracetam 1g Under Fasted Conditions
NCT00826722
Roxane LaboratoriesN/A
CompletedPharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
NCT00884052
Richard H. HaasPhase 1 / Phase 2
TerminatedThe Role of Serotonin in Seizures
NCT00439387
National Institute of Neurological Disorders and Stroke (NINDS)
CompletedA Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Parti
NCT01030094
Janssen Korea, Ltd., Korea
CompletedEpileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Prop
NCT03209323
Medical University of SilesiaN/A
CompletedA Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epi
NCT00361010
The Cleveland ClinicN/A
CompletedBioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions
NCT00864006
SandozPhase 1
RecruitingKetogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
NCT02216500
University of FloridaN/A
CompletedPhase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector
NCT00534378
U.S. Army Office of the Surgeon GeneralPhase 1
CompletedIntranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
NCT00326612
University of UtahPhase 2
UnknownStudy of Bedside EEG to Evaluate Brain Injury in Premature Newborns
NCT00516334
Brigham and Women's Hospital
CompletedTolerability and Efficacy of Depakote-extended Release in the Elderly
NCT00318929
Virginia Commonwealth UniversityN/A
CompletedClinical and Immunological Investigations of Subtypes of Autism
NCT00298246
National Institute of Mental Health (NIMH)
WithdrawnBlood Sugars in Children With Idiopathic Seizures.
NCT00279851
Children's Mercy Hospital Kansas City
CompletedEfficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Inte
NCT00319501
PfizerPhase 3
CompletedA Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
NCT00266604
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 4
CompletedRetigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
NCT00235755
GlaxoSmithKlinePhase 3
CompletedClobazam in Subjects With Lennox-Gastaut Syndrome
NCT00162981
Lundbeck LLCPhase 2
CompletedRetigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00232596
GlaxoSmithKlinePhase 3
CompletedBioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions
NCT00826865
Roxane LaboratoriesN/A
CompletedBioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
NCT00826787
Roxane LaboratoriesN/A
CompletedA Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refra
NCT00233012
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 1
CompletedTopiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures
NCT00113815
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedPregabalin In Partial Seizures Extension Study
NCT00143130
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 3
CompletedReduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neuro
NCT01459692
Medical University of South CarolinaN/A
CompletedUCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
NCT00345475
UCB Pharma
CompletedPregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
NCT00141427
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 4
CompletedBioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
NCT00618046
Roxane LaboratoriesN/A
CompletedChildhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452
Children's Hospital Medical Center, CincinnatiPhase 3
CompletedBioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
NCT00616863
Roxane LaboratoriesN/A
CompletedBioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions
NCT00616681
Roxane LaboratoriesN/A
CompletedThe Effect of Music Periodicity on Interictal Epileptiform Discharges
NCT01515436
Medical University of South CarolinaN/A
CompletedA Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Se
NCT00297349
Janssen Cilag Pharmaceutica S.A.C.I., Greece
CompletedReducing Seizure Frequency Using Cooling of the Head and Neck
NCT00067210
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2
CompletedTOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia
NCT00147030
Imperial College LondonN/A
CompletedEarly Surgical Intervention to Treat Epilepsy
NCT00040326
University of California, Los AngelesPhase 3
CompletedPathogenesis of Adverse Drug Reactions
NCT00224952
Children's Mercy Hospital Kansas City
CompletedBrain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
NCT00001912
National Institute of Allergy and Infectious Diseases (NIAID)
CompletedA Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed o
NCT00231556
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedSearch for Genes Influencing Childhood Absence Epilepsy (CAE) Study
NCT00041951
Icahn School of Medicine at Mount Sinai
CompletedProspective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
NCT00236886
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedDoes Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure
NCT00007670
US Department of Veterans AffairsPhase 3
CompletedA Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagn
NCT00236717
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
TerminatedDilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study
NCT00219479
Penn State UniversityPhase 4
CompletedKetogenic Diet for Child Epilepsy and Seizure Control
NCT00004729
National Institute of Neurological Disorders and Stroke (NINDS)N/A
CompletedTranscranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy
NCT00001666
National Institute of Neurological Disorders and Stroke (NINDS)
CompletedA Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-
NCT00230698
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Se
NCT00236418
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy
NCT00236743
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Gener
NCT00236704
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedMapping the Areas of the Brain Associated With Language in Children With Epilepsy
NCT00001366
National Institute of Neurological Disorders and Stroke (NINDS)
CompletedA Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients Wi
NCT00236756
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy
NCT00266591
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedMetabolic Abnormalities in Children With Epilepsy
NCT00001325
National Institute of Neurological Disorders and Stroke (NINDS)
CompletedA Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.
NCT00236847
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
CompletedA Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With
NCT00236873
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
CompletedA Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With
NCT00236860
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
CompletedA Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With
NCT00236691
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
CompletedA Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilep
NCT00236730
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
CompletedNeuropsychological Evaluation of Psychiatric and Neurological Patients
NCT00001192
National Institute of Mental Health (NIMH)
CompletedMonitoring Patients With Uncontrolled Epilepsy
NCT00001149
National Institute of Neurological Disorders and Stroke (NINDS)